首页> 外文期刊>European journal of pharmaceutics and biopharmaceutics: official journal of Arbeitsgemeinschaft fuer Pharmazeutische Verfahrenstechnik e.V >Novel semi-interpenetrating hydrogel networks with enhanced mechanical properties and thermoresponsive engineered drug delivery, designed as bioactive endotracheal tube biomaterials
【24h】

Novel semi-interpenetrating hydrogel networks with enhanced mechanical properties and thermoresponsive engineered drug delivery, designed as bioactive endotracheal tube biomaterials

机译:具有增强的机械性能和热响应性工程药物传递的新型半互穿水凝胶网络,被设计为具有生物活性的气管导管生物材料

获取原文
获取原文并翻译 | 示例
           

摘要

Thermoresponsive polymeric platforms are used to optimise drug delivery in pharmaceutical systems and bioactive medical devices. However, the practical application of these systems is compromised by their poor mechanical properties. This study describes the design of thermoresponsive semi-interpenetrating polymer networks (s-IPNs) based on cross-linked p(NIPAA) or p(NIPAA-co-HEMA) hydrogels containing poly(ε-caprolactone) designed to address this issue. Using DSC, the lower critical solution temperature of the co-polymer and p(NIPAA) matrices were circa 34 °C and 32 °C, respectively. PCL was physically dispersed within the hydrogel matrices as confirmed using confocal scanning laser microscopy and DSC and resulted in marked changes in the mechanical properties (ultimate tensile strength, Young's modulus) without adversely compromising the elongation properties. P(NIPAA) networks containing dispersed PCL exhibited thermoresponsive swelling properties following immersion in buffer (pH 7), with the equilibrium-swelling ratio being greater at 20 °C than 37 °C and greatest for p(NIPAA)/PCL systems at 20 °C. The incorporation of PCL significantly lowered the equilibrium swelling ratio of the various networks but this was not deemed practically significant for s-IPNs based on p(NIPAA). Thermoresponsive release of metronidazole was observed from s-IPN composed of p(NIPAA)/PCL at 37 °C but not from p(NIPAA-co-HEMA)/PCL at this temperature. In all other platforms, drug release at 20 °C was significantly similar to that at 37 °C and was diffusion controlled. This study has uniquely described a strategy by which thermoresponsive drug release may be performed from polymeric platforms with highly elastic properties. It is proposed that these materials may be used clinically as bioactive endotracheal tubes, designed to offer enhanced resistance to ventilator associated pneumonia, a clinical condition associated with the use of endotracheal tubes where stimulus responsive drug release from biomaterials of significant mechanical properties would be advantageous.
机译:热响应性聚合物平台用于优化药物在制药系统和生物活性医疗设备中的输送。但是,这些系统的实际应用因其较差的机械性能而受到损害。这项研究描述了基于包含聚(ε-己内酯)的交联p(NIPAA)或p(NIPAA-co-HEMA)水凝胶的热响应性半互穿聚合物网络(s-IPN)的设计,旨在解决此问题。使用DSC,共聚物和p(NIPAA)基质的较低临界溶液温度分别约为34°C和32°C。使用共聚焦扫描激光显微镜和DSC证实,PCL物理分散在水凝胶基质中,并导致机械性能(最终拉伸强度,杨氏模量)发生显着变化,而不会不利地影响伸长率性能。浸入缓冲液(pH 7)后,包含分散PCL的P(NIPAA)网络表现出热响应膨胀特性,在20°C时的平衡溶胀率大于37°C,而在20°C时p(NIPAA)/ PCL系统的溶胀率最大C。 PCL的加入显着降低了各种网络的平衡溶胀率,但这对于基于p(NIPAA)的s-IPN并不实用。在此温度下,从由p(NIPAA)/ PCL组成的s-IPN中观察到甲硝唑的热响应释放,但在此温度下未从p(NIPAA-co-HEMA)/ PCL中释放出甲硝唑。在所有其他平台上,药物在20°C下的释放与在37°C下的释放非常相似,并且受扩散控制。这项研究独特地描述了一种策略,通过该策略可以从具有高弹性的聚合物平台上释放热响应性药物。建议将这些材料临床上用作具有生物活性的气管导管,其被设计为提供对呼吸机相关性肺炎的增强抵抗力,这是与使用气管导管相关的临床条件,其中从具有明显机械特性的生物材料中释放刺激响应性药物将是有利的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号